A

Au, Minnie, Emeto, Theophilus I., Power, Jacinta, Vangaveti, Venkat N., and Lai, Hock C. (2019) Emerging therapeutic potential of nanoparticles in pancreatic cancer: a systematic review of clinical trials. In: Bawa, Raj, Szebeni, Janos, Webster, Thomas J., and Audette, Gerald F., (eds.) Immune Aspects of Biopharmaceuticals and Nanomedicines. Pan Stanford Series on Nanomedicine, 3 . CRC Press, Singapore.

B

Billhult, A., Lindholm, C., Gunnarsson, Ronny, and Stener-Victorin, E. (2008) The effect of massage on cellular immunity, endocrine and psychological factors in women with breast cancer: a randomized controlled clinical trial. Autonomic Neuroscience: Basic and Clinical, 140 (1-2). pp. 88-95.

D

Donkor, Moses K., Sarkar, Abira, Savage, Peter A., Franklin, Ruth A., Johnson, Linda K., Jungbluth, Achim A., Allison, James P., and Li, Ming O. (2011) T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-beta 1 Cytokine. Immunity, 35 (1). pp. 123-134.

H

Heinrich, Körner, Riminton, D. Sean, Strickland, Deborah H., Lemckert, Frances A., Pollard, John D., and Sedgwick, Jonathon D. (1997) Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. The Journal of Experimental Medicine, 189 (9). pp. 1585-1590.

K

Körner, Heinrich, Cretney, Erika, Wilhelm, Patricia, Kelly, Janice M., Röllinghoff, Martin, Sedgwick, Jonathon D., and Smyth, Mark J. (2000) Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype. The Journal of Experimental Medicine, 191 (1). pp. 89-96.

Körner, Heinrich, Cook, Matthew, Riminton, D. Sean, Lemckert, Frances A., Hoek, Robert M., Ledermann, Birgit, Köntgen, Frank, de St Groth, Barbara Fazekas, and Sedgwick, Jonathon D. (1997) Distinct roles for lymphotoxin-α and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. European Journal of Immunology, 27 (10). pp. 2600-2609.

Korner, Heinrich, Fritzsche, Ulrike, and Burgert, Hans-Gerhard (1992) Tumor necrosis factor α stimulates expression of adenovirus early region 3 proteins: implications for viral persistence. Proceedings of the National Academy of Sciences of the United States of America, 89 (24). pp. 11857-11861.

L

Lam, Alfred King-Yin, Ong, Kate, and Ho, Yik-Hong (2006) Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 expression. Diseases of the Colon & Rectum, 49 (9). pp. 1275-1283.

P

Pai, Saparna, O'Sullivan, Brendan, Abdul-Jabbar, Ibtissam, Peng, Judy, Connoly, Geoff, Khanna, Rajiv, Thomas, Ranjeny, and thomas, ran (2007) Nasopharyngeal carcinoma-associated Epstein–Barr virus-encoded oncogene latent membrane protein 1 potentiates regulatory T-cell function. Immunology and Cell Biology, 85 (5). pp. 370-377.

Pai, Saparna, O'Sullivan, Brendan J., Cooper, Leanne, Thomas, Ranjeny, and Khanna, Rajiv (2002) RelB nuclear translocation mediated by C-terminal activator regions of Epstein-Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells. Journal of Virology, 76 (4). pp. 1914-1921.

Pai, Saparna, and Khanna, Rajiv (2001) Role of LMP1 in immune control of EBV infection. Seminars in Cancer Biology, 11 (6). pp. 455-460.

W

Wilhelm, Patricia, Ritter, Uwe, Labbow, Stefanie, Donhauser, Norbert, Röllinghoff, Martin, Bogdan, Christian, and Körner, Heinrich (2001) Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. The Journal of Immunology, 166. pp. 4012-40119.